Cargando…

Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol

BACKGROUND: This paper reports on the availability of diagnostic tools and recommended anti-malarials in the 12-month period immediately following the implementation of a new national malaria treatment protocol (NMTP) in Papua New Guinea (PNG). Health worker adherence to the new NMTP is also examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Pulford, Justin, Kurumop, Serah F, Ura, Yangta, Siba, Peter M, Mueller, Ivo, Hetzel, Manuel W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222867/
https://www.ncbi.nlm.nih.gov/pubmed/24279720
http://dx.doi.org/10.1186/1475-2875-12-433
_version_ 1782343121486479360
author Pulford, Justin
Kurumop, Serah F
Ura, Yangta
Siba, Peter M
Mueller, Ivo
Hetzel, Manuel W
author_facet Pulford, Justin
Kurumop, Serah F
Ura, Yangta
Siba, Peter M
Mueller, Ivo
Hetzel, Manuel W
author_sort Pulford, Justin
collection PubMed
description BACKGROUND: This paper reports on the availability of diagnostic tools and recommended anti-malarials in the 12-month period immediately following the implementation of a new national malaria treatment protocol (NMTP) in Papua New Guinea (PNG). Health worker adherence to the new NMTP is also examined and comparisons made with previously reported pre-implementation findings. METHODS: A countrywide cross-sectional survey in randomly selected primary health care facilities (n = 88). Data were collected via passive observation of the clinical case management of fever or suspected malaria patients and via an interviewer administered questionnaire completed with the officer in charge of each participating health care facility. RESULTS: Malaria rapid diagnostic tests (RDTs) and the new first-line anti-malarial medication, artemether-lumefantrine (AL), were available in 53.4% and 51.1% of surveyed heath facilities, respectively. However, they were more widely available in the larger health centres as compared to the smaller aid-posts (90.2% vs. 21.3% and 87.8% vs. 19.2%, respectively). Overall, 68.3% of observed fever cases (n = 445) were tested for malaria by RDT and 39% prescribed an anti-malarial, inclusive of 98.2% of RDT positive patients and 19.8% of RDT negative cases. The availability and use of malaria RDTs was greater in the current survey as compared to pre-implementation of the new NMTP (8.9% vs. 53.4% & 16.2% vs. 68.3%, respectively) as was the availability of AL (0% vs. 51.1%). The percentage of fever patients prescribed anti-malarials decreased substantially post implementation of the new NMTP (96.4% vs. 39.0%). CONCLUSIONS: PNG has achieved high coverage of malaria RDTs and AL at the health centre level, but these resources have yet to reach the majority of aid-posts. Malaria case management practice has substantially changed in the 12-month period immediately following the new NMTP, although full protocol adherence was rarely observed.
format Online
Article
Text
id pubmed-4222867
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42228672014-11-07 Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol Pulford, Justin Kurumop, Serah F Ura, Yangta Siba, Peter M Mueller, Ivo Hetzel, Manuel W Malar J Research BACKGROUND: This paper reports on the availability of diagnostic tools and recommended anti-malarials in the 12-month period immediately following the implementation of a new national malaria treatment protocol (NMTP) in Papua New Guinea (PNG). Health worker adherence to the new NMTP is also examined and comparisons made with previously reported pre-implementation findings. METHODS: A countrywide cross-sectional survey in randomly selected primary health care facilities (n = 88). Data were collected via passive observation of the clinical case management of fever or suspected malaria patients and via an interviewer administered questionnaire completed with the officer in charge of each participating health care facility. RESULTS: Malaria rapid diagnostic tests (RDTs) and the new first-line anti-malarial medication, artemether-lumefantrine (AL), were available in 53.4% and 51.1% of surveyed heath facilities, respectively. However, they were more widely available in the larger health centres as compared to the smaller aid-posts (90.2% vs. 21.3% and 87.8% vs. 19.2%, respectively). Overall, 68.3% of observed fever cases (n = 445) were tested for malaria by RDT and 39% prescribed an anti-malarial, inclusive of 98.2% of RDT positive patients and 19.8% of RDT negative cases. The availability and use of malaria RDTs was greater in the current survey as compared to pre-implementation of the new NMTP (8.9% vs. 53.4% & 16.2% vs. 68.3%, respectively) as was the availability of AL (0% vs. 51.1%). The percentage of fever patients prescribed anti-malarials decreased substantially post implementation of the new NMTP (96.4% vs. 39.0%). CONCLUSIONS: PNG has achieved high coverage of malaria RDTs and AL at the health centre level, but these resources have yet to reach the majority of aid-posts. Malaria case management practice has substantially changed in the 12-month period immediately following the new NMTP, although full protocol adherence was rarely observed. BioMed Central 2013-11-27 /pmc/articles/PMC4222867/ /pubmed/24279720 http://dx.doi.org/10.1186/1475-2875-12-433 Text en Copyright © 2013 Pulford et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pulford, Justin
Kurumop, Serah F
Ura, Yangta
Siba, Peter M
Mueller, Ivo
Hetzel, Manuel W
Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol
title Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol
title_full Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol
title_fullStr Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol
title_full_unstemmed Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol
title_short Malaria case management in Papua New Guinea following the introduction of a revised treatment protocol
title_sort malaria case management in papua new guinea following the introduction of a revised treatment protocol
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222867/
https://www.ncbi.nlm.nih.gov/pubmed/24279720
http://dx.doi.org/10.1186/1475-2875-12-433
work_keys_str_mv AT pulfordjustin malariacasemanagementinpapuanewguineafollowingtheintroductionofarevisedtreatmentprotocol
AT kurumopserahf malariacasemanagementinpapuanewguineafollowingtheintroductionofarevisedtreatmentprotocol
AT urayangta malariacasemanagementinpapuanewguineafollowingtheintroductionofarevisedtreatmentprotocol
AT sibapeterm malariacasemanagementinpapuanewguineafollowingtheintroductionofarevisedtreatmentprotocol
AT muellerivo malariacasemanagementinpapuanewguineafollowingtheintroductionofarevisedtreatmentprotocol
AT hetzelmanuelw malariacasemanagementinpapuanewguineafollowingtheintroductionofarevisedtreatmentprotocol